Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Internet and telephone intervention to support patients discontinuing long-term antidepressants in primary care: the REDUCE research programme including RCT.
Kendrick T, Stuart B, Bowers H, Haji Sadeghi M, Page H, Dowrick C, Moore M, Gabbay M, Leydon G, Lily Yao G, Zhu S, Little P, Griffiths G, Lewis G, May C, Moncrieff J, Johnson CF, Macleod U, Gilbody S, Dewar-Haggart R, Williams S, O’Brien W, Tiwari R, Woods C, Patel T, Khan N, Maund E, van Ginneken N, Din A, Reidy C, Lucier R, Palmer B, Becque T, Masood Y, Thompson N, van Leeuwen E, Glowacka M, Geraghty AWA. Kendrick T, et al. Among authors: van leeuwen e. Southampton (UK): National Institute for Health and Care Research; 2025 Jul. Southampton (UK): National Institute for Health and Care Research; 2025 Jul. PMID: 40700552 Free Books & Documents. Review.
The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis.
Goodfellow L, Procter SR, Koltai M, Waterlow NR, Filipe JAN, Wong CKH, van Leeuwen E, Eggo RM, Jit M; WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment and project team; Next-generation influenza vaccine impact modelling contributors. Goodfellow L, et al. Among authors: van leeuwen e. PLoS Med. 2025 Jun 30;22(6):e1004655. doi: 10.1371/journal.pmed.1004655. eCollection 2025 Jun. PLoS Med. 2025. PMID: 40587557 Free PMC article.
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Pothast CR, Hofsink Q, Haggenburg S, Dijkland RC, Van de Meent M, Van Dijk K, Bhoekhan MS, Haverkate NJE, Van Meerloo J, Falkenburg JHF, De Groen RAL, Broers AEC, Van Doesum JA, Van Binnendijk RS, Den Hartog G, Lissenberg-Witte BI, Kater AP, Smits GP, Wouters D, Van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Van Baarle D, De Vries RD, Van Meerten T, Mutsaers PGNJ, Goorhuis A, Nijhof IS, Hazenberg MD, Heemskerk MHM, Rutten CE; COBRA KAI study team. Pothast CR, et al. Among authors: van leeuwen emm. Haematologica. 2025 May 29. doi: 10.3324/haematol.2024.287136. Online ahead of print. Haematologica. 2025. PMID: 40438989 Free article.
IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency.
Körholz J, Tromp SAM, Dalm VASH, de Bie M, de Bree GJ, van Leeuwen EMM, Fraaij PLA, Jansen MH, Hollink IHIM, Nagelkerke SQ, Russ S, Scholze AK, Soomann M, Wiedemuth R, Pachlopnik Schmid J, Hanitsch LG, Schuetz C, Kuijpers TW, IJspeert H. Körholz J, et al. Among authors: van leeuwen emm. J Allergy Clin Immunol. 2025 Aug;156(2):279-293. doi: 10.1016/j.jaci.2025.04.033. Epub 2025 May 20. J Allergy Clin Immunol. 2025. PMID: 40403933 Free article.
579 results